Evidence map›Paper›PMID 23410756›Full record

ArticleBiochemical and biophysical research communications2013

Oxytocin modulates mTORC1 pathway in the gut.

Benjamin Y Klein, Hadassah Tamir, David L Hirschberg, Sara B Glickstein, Martha G Welch

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Fantastic voyage:Comprehensive psychoneuroendocrinology · 2024
    Review
  6. Review
  7. Oxytocin and oxygen: the evolution of a solution to the 'stress of life'.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  8. Article
  9. Review
  10. TRPV1, Nrf2, and COVID-19: Could Oxytocin Have a Beneficial Role to Play?International archives of allergy and immunology · 2022
    Article
  11. Review
  12. Is Oxytocin "Nature's Medicine"?Pharmacological reviews · 2020
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Benjamin Y KleinDepartment of Pathology & Cell Biology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. benjamin.klein@gmail.com
Hadassah Tamir
David L Hirschberg
Sara B Glickstein
Martha G Welch
Columbia University · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
NCATS NIH HHS UL1 TR000040NCRR NIH HHS UL1 RR024156NIAID NIH HHS U19 AI057229
6 · The paper itself

Abstract

Our recent findings of a weaning-related pattern of oxytocin (OT) and OT receptor (OTR) expression in the rat enteric nervous system and in villus-crypt enterocytes, together with the known high level and stability of OT in breast milk support that OT may play a role in gut function and development. We previously described a biphasic dose-response of the PI3K/Akt pathway in gut cells treated with OT. Activation peaked at 62.5 nM OT (30 min) and coincided with OTR internalization. Here we use automated Western blotting to further explore OT-elicited changes in Akt and pAkt(T308), as well as in downstream substrates p70 S6 kinase-1 (S6K1) and eIF-4E binding protein 1 (4E-BP1). Relative to fresh growth medium (FGM) alone, our results showed OT in FGM reduced the abundance and phosphorylation of S6K1 and the phosphorylation of 4E-BP1, both substrates of mammalian target of rapamycin complex 1 (mTORC1). Phosphorylation of mTORC1 regulator, Raptor(S792), was increased by high and low OT concentrations, with predicted inhibitory effects on mTORC1. OT thus downregulates anabolic effects induced by FGM activity catalyzed by mTORC1. OT is a regulator of the PI3K/Akt/mTORC1 pathway in Caco2BB cells and may modulate translation in gut cells.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCaco-2 CellsEukaryotic Initiation Factor-4EGastrointestinal TractHumansMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesOxytocinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRegulatory-Associated Protein of mTORRibosomal Protein S6 Kinases, 70-kDaSignal TransductionTOR Serine-Threonine KinasesAdaptor Proteins, Signal TransducingEukaryotic Initiation Factor-4EMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesOxytocinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRegulatory-Associated Protein of mTORribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaRPTOR protein, humanTOR Serine-Threonine Kinases

Identifiers

PMID23410756
PMCPMC3619035
OpenAlexW1988673143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.